Choline alfoscerate, also known as alpha-glycerylphosphorylcholine (alpha-GPC, AGPC) is a nootropic choline-containing phospholipid. It is a hydrolysis product of lecithin, which is a ubiquitous natural constituent of biological organisms and human food. In Europe, choline alfoscerate is a prescription medication for the treatment of Alzheimer's disease. It is available in two forms; one is taken by mouth, and the other is given as an injection. In the United States, choline alfoscerate is only available as a dietary supplement, mostly in products promoted to improve memory. Other uses for choline alfoscerate include treatment of various kinds of dementia, stroke, and transient ischemic attack (TIA). Choline alfoscerate is also used for improving memory, thinking skills, and learning.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), and to obtain the following information:
To order an OEL/ADE monograph for Choline Alfoscerate, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’s OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.